Maria Diaz Rosario
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maria Diaz Rosario has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andra Valentina Krauze
Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA
1 shared publication - Erdal Tasci
Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, CRC, Bethesda, MD 20892, USA
1 shared publication - Harpreet Kaur
Department of Computational Biology, Indraprastha Institute of Information Technology
1 shared publication - Kevin Camphausen
Radiation Oncology Branch, NCI, NIH, Bethesda, MD 20892
1 shared publication - Mary Sproull
Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland
1 shared publication - Uma Shankavaram
Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA
1 shared publication
Latest Publications
- Open Access
- 30 August 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (9) , 1203
The Next Frontier in Health Disparities—A Closer Look at Exploring Sex Differences in Glioma Data and Omics Analysis, from Bench to Bedside and Back
Sex differences are increasingly being explored and reported in oncology, and glioma is no exception. As potentially meaningful sex differences are uncovered, existing gender-derived disparities mirror data generated in retrospective and prospective trials, real-world large-scale data sets, and bench work involving animals and cell lines. The resulting disparities at the data level are wide-ranging, potentially resulting in both adverse outcomes and failure to identify and exploit therapeutic benefits. We set out to analyze the literature on women’s data disparities in glioma by exploring the origins of data in this area to understand the representation of women in study samples and omics analyses. Given the current emphasis on inclusive study design and research, we wanted to explore if sex bias continues to exist in present-day data sets and how sex differences in data may impact conclusions derived from large-scale data sets, omics, biospecimen analysis, novel interventions, and standard of care management.
- 30 August 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (9) , 1203
Open AccessThe Next Frontier in Health Disparities—A Closer Look at Exploring Sex Differences in Glioma Data and Omics Analysis, from Bench to Bedside and Back
Sex differences are increasingly being explored and reported in oncology, and glioma is no exception. As potentially meaningful sex differences are uncovered, existing gender-derived disparities mirror data generated in retrospective and prospective trials, real-world large-scale data sets, and bench work involving animals and cell lines. The resulting disparities at the data level are wide-ranging, potentially resulting in both adverse outcomes and failure to identify and exploit therapeutic benefits. We set out to analyze the literature on women’s data disparities in glioma by exploring the origins of data in this area to understand the representation of women in study samples and omics analyses. Given the current emphasis on inclusive study design and research, we wanted to explore if sex bias continues to exist in present-day data sets and how sex differences in data may impact conclusions derived from large-scale data sets, omics, biospecimen analysis, novel interventions, and standard of care management.